A Survey on Blood Transfusions in Major Artrhoplasty Operations

Status Completed

Clinical Trial Summary

The rate of hip, knee arthroplasties and their revision are increasing every year. The incidence of blood transfusion in these operations are reported 18%, 68%, and 39%, 67%, respectively. Blood transfusion is known to increase the risk of pulmonary, septic, wound and thromboembolic complications and is related to mortality. Restrictive transfusion protocols has cost-effective results in terms of reducing these complications, promoting early discharge and reduced frequency of re-admission.

Within this context, we aimed to evaluate the transfusion practice in our hospital, define the transfusion indicators and compare the transfused and non transfused patients in terms of recovery.

Clinical Trial Description

After obtaining ethical approval Patients undergoing hip or knee arthroplasty or revision arthroplasty will be included in this prospective observational study.

Patient characteristics (age , gender, body mass index, ASA physical status, anticoagulant medication) Preoperative: hemoglobin, hematocrit, platelet, INR, APTT, PT values, the precence of preoperative anemia, anemia treatment modalities will be recorded.

Intraopreative: type and duration of surgery, anesthesia method, monitoring methods used, the amount of intraoprative adminestred fluids (crystalloid-colloid), amount of hemorrhage Postoperative: hemoglobin-hematocrit-platelet leve The amount of blood transfusion and the product used (erythrocyte suspension, fresh frozen plasma, thrombocyte-fibrinogen-factor concentration-cryoprecipitate-other ) Hemoglobin-hematocrit-platelet level before and after transfusion Indications for transfusion; hemoglobin threshold / physiological transfusion indicator; tachycardia, hypotension, low flow rate, desaturation, low SvO2, inotropic requirement, etc. / comorbidities / monitorisation findings, other, Discharge time of patients Early upright position (postoperative 2nd day), information on walking capacities (TUG - The Time Up and Go test) will be recorded and compared between transfused and non-transfused patients ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03282201
Study type	Observational
Source	Diskapi Teaching and Research Hospital
Contact
Status	Completed
Phase
Start date	October 15, 2017
Completion date	June 20, 2018

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03940651` - Cardiac and Renal Biomarkers in Arthroplasty Surgery	Phase 4
Completed	`NCT05593341` - Opioid Education in Total Knee Arthroplasty	N/A
Not yet recruiting	`NCT05290818` - Total Versus Robotic Assisted Unicompartmental Knee Replacement	N/A
Withdrawn	`NCT04099355` - Investigating the Effect of Dronabinol on Post-surgical Pain	Early Phase 1
Recruiting	`NCT04924205` - A Comparison Of Primary TKA Rehabilitation Using A Smart Orthotic Versus Outpatient Physical Therapy	N/A
Completed	`NCT05399043` - Experience of Use and Biopsychosocial Effects of Robotic and Virtual Reality Devices in Neuromotor Rehabilitation	N/A
Terminated	`NCT03185117` - Opioid Consumption After Hospital Discharge in Orthopedic Surgery
Completed	`NCT04118023` - 7T MRI to Evaluate Cartilage Defects in the Knee
Terminated	`NCT03260699` - Economic and Functional Impact of Peri-Operative Bracing for Primary Total Knee Arthroplasty (TKA)	N/A
Recruiting	`NCT03283878` - Antibiotic Prophylaxis in Patients Undergoing Elective TKA- Multi-center Trial	Phase 4
Completed	`NCT03133481` - Adductor Canal Block Versus Femoral Nerve Block for Total Knee Arthroplasty	Phase 3
Active, not recruiting	`NCT04684160` - Comparison of Joint Awareness Between Fixed-bearing and Mobile-bearing Total Knee Arthroplasty Using Titanium-nitride Coated Posterior-stabilized Prostheses	N/A
Recruiting	`NCT06259032` - Comparative Effect of Mechanical and Functional Alignment in Bilateral Total Knee Arthroplasty on Ankle Alignment	N/A
Completed	`NCT02928562` - The Impaction of Exercise Training on Bone Mineral Density in Patients After Total Knee Arthroplasty	N/A
Completed	`NCT04481711` - Total Knee Arthroplasty and Clinical Findings	N/A
Recruiting	`NCT01135160` - Evaluation of Weight Bearing After Total Hip and Knee Replacement
Completed	`NCT03921034` - IPACK Nerve Block for Total Knee Arthroplasty	Phase 4
Active, not recruiting	`NCT05248815` - Muscle Strength and Total Knee Replacement
Not yet recruiting	`NCT06024161` - Weight Change and the Risk of Chronic Pain Following Hip and Knee Arthroplasties
Recruiting	`NCT05853497` - A Multi-Component Weight Loss Intervention to Improve Outcomes of Total Knee Replacement	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.